retatrutide parkinson's disease trial nct The NADPARK study: A randomized phase I of nicotinamide riboside supplementation in Parkinson's research trial numbers remain
Pay in 4 interest-free payments of $6.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16





























